Inventor

Michael Dolberg Rasmussen

Inventor
Vallensbaek, DK

Overview

30→
Patents
1998–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes20%
C07KPeptides10%
C07DHeterocyclic compounds9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture8%
C12YEnzymes8%
Y02PClimate change mitigation technologies in the production or processing of goods6%
C07CAcyclic or carbocyclic compounds5%
C11DDetergent compositions4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
PatentTitleYear
11,067,677Ultrasound imaging transducer array with integrated apodization202110,280,426Method for stable gene-amplification in a bacterial host cell20199,458,468'Method for stable gene-amplification in a bacterial host cell'20168,685,653'Method for stable gene-amplification in a bacterial host cell'20148,569,029'DNase expression in recombinant host cells'20138,535,911'Cell with improved secretion mediated by MrgA protein or homologue'20138,268,583'Cell with improved secretion mediated by MrgA protein or homologue'20128,227,227'DNase expression in recombinant host cells'20128,168,417'Bacillus licheniformis chromosome'20128,034,926'Methods of manufacturing crystalline forms of rapamycin analogs'20118,030,326'Crystalline forms of rapamycin analogs'20117,951,556'Mutated prokaryotic cells with high secretion-levels'20117,863,032'Bacillus licheniformis chromosome-encoded endoglucanase'20117,820,812'Methods of manufacturing crystalline forms of rapamycin analogs'20107,812,032'Crystalline forms of rapamycin analogs'20107,700,322'Method for stable gene-amplification in a bacterial host cell'20107,494,798'Bacillus licheniformis chromosome'20097,189,849'Synthesis of acyclic nucleoside derivatives'20076,878,844'Synthesis of acyclic nucleoside derivatives'20056,762,040'Method for increasing gene copy number in a host cell and resulting host cell'20046,613,936'Synthesis of acyclic nucleoside derivatives'20036,576,763'Acyclic nucleoside derivatives'20036,437,106'Process for preparing 6-o-substituted erythromycin derivatives'20026,326,206'In vivo recombination'20016,184,376'Synthesis of acyclic nucleoside derivatives'20016,017,751'Process and composition for desizing cellulosic fabric with an enzyme hybrid'20006,015,783'Process for removal or bleaching of soiling or stains from cellulosic fabric'20005,935,837'DNA constructs and methods of producing xylose isomerase'19995,856,164'Alkaline bacillus amylase'19995,824,531'Alkaline bacilus amylase'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–1999Based in Bagsvaerd, DK· patent location history
1999–2000Patents assigned to NOVO NORDISK AS (4)· patent assignee history
1999–2019Based in Vallensbaek, DK· patent location history
2001–2019Patents assigned to NOVOZYMES AS (12)· patent assignee history
2001–2007Based in Kenosha, WI, US· patent location history
2002–2011Patents assigned to ABBOTT LAB (5)· patent assignee history
2003–2007Patents assigned to MEDIVIR AB (4)· patent assignee history
2009–2012Based in Vallensbæk, DK· patent location history
2010–2011Based in Racine, WI, US· patent location history
2012–2014Patents assigned to RASMUSSEN MICHAEL DOLBERG (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVOZYMES AS122001–2019
RASMUSSEN MICHAEL DOLBERGself62012–2014
ABBOTT LAB52002–2011
MEDIVIR AB42003–2007
NOVO NORDISK AS41999–2000
Locations
LocationPatentsSpan
Vallensbaek, DK141999–2019
Kenosha, WI, US62001–2007
Racine, WI, US42010–2011
Vallensbæk, DK32009–2012
Bagsvaerd, DK21998–1999